Erba E - Search Results

1

Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.

Carrassa L, Broggini M, Erba E, Damia G. Carrassa L, et al. Among authors: erba e. Cell Cycle. 2004 Sep;3(9):1177-81. Epub 2004 Sep 13. Cell Cycle. 2004. PMID: 15326376

2

U2OS cells lacking Chk1 undergo aberrant mitosis and fail to activate the spindle checkpoint.

Carrassa L, Sanchez Y, Erba E, Damia G. Carrassa L, et al. Among authors: erba e. J Cell Mol Med. 2009 Aug;13(8A):1565-76. doi: 10.1111/j.1582-4934.2009.00362.x. J Cell Mol Med. 2009. PMID: 19778378 Free PMC article.

3

Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.

Vikhanskaya F, Erba E, D'Incalci M, Broggini M. Vikhanskaya F, et al. Among authors: erba e. Exp Cell Res. 1996 Sep 15;227(2):380-5. doi: 10.1006/excr.1996.0288. Exp Cell Res. 1996. PMID: 8831577

4

DNA Damage Induces p53-dependent Down-regulation of hCHK1.

Damia G, Sanchez Y, Erba E, Broggini M. Damia G, et al. Among authors: erba e. J Biol Chem. 2001 Apr 6;276(14):10641-5. doi: 10.1074/jbc.M007178200. Epub 2001 Jan 4. J Biol Chem. 2001. PMID: 11152453 Free article.

5

Unique features of the mode of action of ET-743.

D'Incalci M, Erba E, Damia G, Galliera E, Carrassa L, Marchini S, Mantovani R, Tognon G, Fruscio R, Jimeno J, Faircloth GT. D'Incalci M, et al. Among authors: erba e. Oncologist. 2002;7(3):210-6. doi: 10.1634/theoncologist.7-3-210. Oncologist. 2002. PMID: 12065793 Free article. Review.

6

Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity.

Simone M, Erba E, Damia G, Vikhanskaya F, Di Francesco AM, Riccardi R, Bailly C, Cuevas C, Fernandez Sousa-Faro JM, D'Incalci M. Simone M, et al. Among authors: erba e. Eur J Cancer. 2005 Oct;41(15):2366-77. doi: 10.1016/j.ejca.2005.05.015. Epub 2005 Sep 21. Eur J Cancer. 2005. PMID: 16181779

7

Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53.

Vikhanskaya F, Erba E, D'Incalci M, Broggini M. Vikhanskaya F, et al. Among authors: erba e. Nucleic Acids Res. 1994 Mar 25;22(6):1012-7. doi: 10.1093/nar/22.6.1012. Nucleic Acids Res. 1994. PMID: 8152906 Free PMC article.

8

Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action.

Erba E, Bergamaschi D, Bassano L, Damia G, Ronzoni S, Faircloth GT, D'Incalci M. Erba E, et al. Eur J Cancer. 2001 Jan;37(1):97-105. doi: 10.1016/s0959-8049(00)00357-9. Eur J Cancer. 2001. PMID: 11165136

9

Combination of PI3K/mTOR inhibitors: antitumor activity and molecular correlates.

Mazzoletti M, Bortolin F, Brunelli L, Pastorelli R, Di Giandomenico S, Erba E, Ubezio P, Broggini M. Mazzoletti M, et al. Among authors: erba e. Cancer Res. 2011 Jul 1;71(13):4573-84. doi: 10.1158/0008-5472.CAN-10-4322. Epub 2011 May 20. Cancer Res. 2011. PMID: 21602434

10

ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patients.

Ricci F, Bernasconi S, Porcu L, Erba E, Panini N, Fruscio R, Sina F, Torri V, Broggini M, Damia G. Ricci F, et al. Among authors: erba e. Am J Cancer Res. 2013 Apr 3;3(2):221-9. Print 2013. Am J Cancer Res. 2013. PMID: 23593543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters